🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/06/1985 | 0,0212 USD |
| 28/02/1985 | 0,0212 USD |
| 03/12/1984 | 0,0212 USD |
| 31/08/1984 | 0,0199 USD |
| 29/05/1984 | 0,0199 USD |
| 01/03/1984 | 0,0199 USD |
| 29/11/1983 | 0,0199 USD |
| 29/08/1983 | 0,0186 USD |
| 31/05/1983 | 0,0186 USD |
| 28/02/1983 | 0,0186 USD |
| 30/11/1982 | 0,0186 USD |
| 30/08/1982 | 0,0186 USD |
| 01/06/1982 | 0,0186 USD |
| 01/03/1982 | 0,0186 USD |
| 01/12/1981 | 0,0186 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/03/2025 | 89,25 | 90,27 | 88,37 | 89,76 | +0,59% | 2,13% | 15.003.000 |
| 28/03/2025 | 88,20 | 90,14 | 87,67 | 89,23 | +1,86% | 2,80% | 12.393.500 |
| 27/03/2025 | 88,50 | 88,56 | 87,38 | 87,60 | -0,58% | 1,33% | 12.931.900 |
| 26/03/2025 | 88,24 | 89,32 | 87,31 | 88,11 | +0,27% | 2,28% | 13.808.800 |
| 25/03/2025 | 92,31 | 92,31 | 87,08 | 87,87 | -4,81% | 5,67% | 20.640.200 |
| 24/03/2025 | 92,90 | 93,11 | 91,56 | 92,31 | -0,86% | 1,67% | 16.950.100 |
| 21/03/2025 | 94,58 | 94,68 | 93,07 | 93,11 | -1,71% | 1,70% | 68.435.800 |
| 20/03/2025 | 94,00 | 95,16 | 93,68 | 94,73 | +0,76% | 1,57% | 12.970.200 |
| 19/03/2025 | 95,25 | 95,43 | 93,64 | 94,02 | -0,74% | 1,88% | 11.355.900 |
| 18/03/2025 | 95,23 | 95,41 | 93,84 | 94,72 | -0,07% | 1,65% | 8.670.100 |
| 17/03/2025 | 93,65 | 95,30 | 93,08 | 94,79 | +0,23% | 2,37% | 12.237.900 |
| 14/03/2025 | 94,28 | 94,88 | 93,45 | 94,57 | -0,15% | 1,52% | 12.681.100 |
| 13/03/2025 | 93,40 | 96,34 | 93,40 | 94,71 | +1,46% | 3,15% | 16.570.100 |
| 12/03/2025 | 94,07 | 94,40 | 92,86 | 93,35 | -1,46% | 1,64% | 11.896.000 |
| 11/03/2025 | 94,98 | 95,38 | 93,58 | 94,73 | -0,53% | 1,90% | 21.734.800 |
| 10/03/2025 | 94,69 | 97,00 | 94,69 | 95,23 | +0,61% | 2,44% | 20.897.600 |
| 07/03/2025 | 94,26 | 97,37 | 93,85 | 94,65 | +0,69% | 3,73% | 24.100.900 |
| 06/03/2025 | 93,13 | 94,05 | 91,78 | 94,00 | +0,87% | 2,44% | 11.300.200 |
| 05/03/2025 | 91,08 | 93,45 | 90,50 | 93,19 | +0,68% | 3,24% | 13.117.100 |
| 04/03/2025 | 93,57 | 95,36 | 92,32 | 92,56 | -0,63% | 3,25% | 15.073.000 |
| 03/03/2025 | 91,78 | 93,21 | 91,78 | 93,15 | +0,98% | 1,56% | 13.636.100 |
| 28/02/2025 | 90,71 | 92,35 | 90,71 | 92,25 | +1,84% | 1,81% | 15.482.100 |
| 27/02/2025 | 89,35 | 90,97 | 89,25 | 90,58 | +1,34% | 1,93% | 10.717.500 |
| 26/02/2025 | 91,30 | 91,37 | 88,86 | 89,38 | -2,24% | 2,75% | 13.534.200 |
| 25/02/2025 | 91,75 | 93,06 | 90,44 | 91,43 | +0,18% | 2,86% | 18.417.300 |
| 24/02/2025 | 89,71 | 91,85 | 88,93 | 91,27 | +1,98% | 3,25% | 19.452.300 |
| 21/02/2025 | 88,00 | 89,53 | 87,01 | 89,50 | +2,08% | 2,86% | 15.678.900 |
| 20/02/2025 | 85,90 | 87,70 | 85,90 | 87,68 | +2,43% | 2,10% | 14.851.500 |
| 19/02/2025 | 83,24 | 85,63 | 82,85 | 85,60 | +2,77% | 3,34% | 17.435.100 |
| 18/02/2025 | 81,13 | 83,59 | 81,04 | 83,29 | +0,34% | 3,14% | 25.897.800 |